Mark W. Schwartz

Mark W. Schwartz

Chairman chez MWS Strategic Advisors LLC

68 ans
Health Technology
Consumer Services
Commercial Services

Profil

Mark W.
Schwartz
is currently the Chairman of MWS Strategic Advisors LLC, Director of Biotechnology Innovation Organization, Director of NeoLight LLC, and Independent Director of SquareX Pharmaceuticals Corp.
He was previously the President & CEO of Bayhill Therapeutics, President, CEO & Director of Galena Biopharma, President & CEO of Apthera, President & CEO of Calyx Therapeutics, Managing Director-Life Sciences of Arizona Science & Technology Enterprises LLC, Executive Director of Targazyme, and Chief Commercial Officer of Trega Biosciences.
He also served as the COO & Executive VP of Phio Pharmaceuticals Corp.
Schwartz holds a doctorate from Arizona State University and an undergraduate degree from Grinnell College.

Postes actifs de Mark W. Schwartz

SociétésPosteDébut
Director/Board Member -
Director/Board Member 01/11/2022
MWS Strategic Advisors LLC Chairman -
Director/Board Member -
Tous les postes actifs de Mark W. Schwartz

Anciens postes connus de Mark W. Schwartz

SociétésPosteFin
Chief Executive Officer 31/01/2017
Arizona Science & Technology Enterprises LLC Corporate Officer/Principal 01/01/2004
Calyx Therapeutics, Inc. President 01/01/2003
Corporate Officer/Principal 01/01/2001
Director/Board Member -
Voir l'expérience en détail de Mark W. Schwartz

Formation de Mark W. Schwartz

Arizona State University Doctorate Degree
Grinnell College Undergraduate Degree

Expériences
Fonctions occupées

Actives

Inactives

Sociétés cotées

Entreprise privées

Voir l'expérience en détail de Mark W. Schwartz

Relations

100 +

Relations au 1er degré

14

Entreprises liées au 1er degré

Homme

Femme

Administrateurs

Exécutifs

Voir le réseau personnel

Sociétés liées

Sociétés cotées1
PHIO PHARMACEUTICALS CORP.

Health Technology

Entreprise privées11

Health Technology

Health Technology

Commercial Services

Health Technology

Health Services

Arizona Science & Technology Enterprises LLC

Calyx Therapeutics, Inc.

Health Technology

Health Technology

Health Technology

MWS Strategic Advisors LLC

Voir les connexions sociétés
  1. Bourse
  2. Insiders
  3. Mark W. Schwartz